Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Liver Tumor, Metastatic Liver”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Early research (Phase 1)Looking for participantsNCT05791448
What this trial is testing

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Who this might be right for
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more
University of Southern California 36
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Not applicableStudy completedNCT02722395
What this trial is testing

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer From Any Cancer Site
Duke University 5
Not applicableStudy completedNCT05172635
What this trial is testing

Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer

Who this might be right for
Gastrointestinal Neoplasm
Klinik Favoriten 100
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Not applicableStudy completedNCT00408122
What this trial is testing

Evaluation of Preoperative Investigations in Patients With Liver Cancer

Who this might be right for
Primary Liver CancerLiver Metastasis
Odense University Hospital 77
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableLooking for participantsNCT06486454
What this trial is testing

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Who this might be right for
Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more
HistoSonics, Inc. 5,000
Testing effectiveness (Phase 2)Study completedNCT00511862
What this trial is testing

TheraSphere for the Treatment of Liver Metastases

Who this might be right for
Colorectal CancerCarcinoma, NeuroendocrineNeoplasm Metastasis
Boston Scientific Corporation 151
Early research (Phase 1)Study completedNCT00001587
What this trial is testing

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Who this might be right for
Liver NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT02753881
What this trial is testing

Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer

Who this might be right for
Liver Cancer
Yale University 30
Testing effectiveness (Phase 2)Ended earlyNCT00005944
What this trial is testing

Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic CancerPrimary Peritoneal Cavity Cancer
UNICANCER
Testing effectiveness (Phase 2)Study completedNCT00006010
What this trial is testing

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Alliance for Clinical Trials in Oncology 25
Not applicableStudy completedNCT02966509
What this trial is testing

Engagement of Patients With Advanced Cancer

Who this might be right for
End of LifeAdvanced CancerLung Neoplasm+11 more
Stanford University 213
Testing effectiveness (Phase 2)UnknownNCT00514930
What this trial is testing

Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver

Who this might be right for
Liver Cancer
University of Thessaly
Large-scale testing (Phase 3)Study completedNCT01721954
What this trial is testing

FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Sirtex Medical 209
Not applicableStudy completedNCT00728650
What this trial is testing

A Retrospective Review of Malignant Liver Tumors

Who this might be right for
Liver Cancer
University of Oklahoma 228
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Load More Results